<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Vanepercyandroberts - Latest News</title>
<link href="https://news.prfree.org/rss/vanepercyandroberts/latest.xml"></link>
<updated>2026-07-21T22:19:36+00:00</updated>
<id>urn:uuid:77284879-edba-0007-eadf-4dac5ae0bdd7</id>
<entry>
<title>Medicine review of 135,000 atrial fibrillation patients saved lives and pounds</title>
<link href="https://news.prfree.org/@vanepercyandroberts/medicine-review-of-135-000-atrial-fibrillation-patients-saved-lives-and-pounds-86kpn5yeakr4"></link>
<id>urn:uuid:ee704739-1b36-9037-a61d-950bee32834e</id>
<summary type="html"><![CDATA[A review of 135,000 patients with atrial fibrillation led to over 25,000 medical interventions, prevented hundreds of strokes and saved the NHS millions of pounds.]]></summary>
<updated>2016-10-07T14:32:29+00:00</updated>
</entry>
<entry>
<title>Verseon presents low bleeding risk anticoagulants at international medical conference</title>
<link href="https://news.prfree.org/@vanepercyandroberts/verseon-presents-low-bleeding-risk-anticoagulants-at-international-medical-conference-b7kxxexx6kry"></link>
<id>urn:uuid:3740740b-c63b-ec27-9e91-a8f021b8fad3</id>
<summary type="html"><![CDATA[Verseon’s new class of anticoagulants are part of a growing portfolio of drug programs being developed with the aid of the Company’s proprietary, computational drug discovery platform]]></summary>
<updated>2016-02-29T14:53:39+00:00</updated>
</entry>
<entry>
<title>MR Solutions&#039; new imaging modality</title>
<link href="https://news.prfree.org/@vanepercyandroberts/mr-solutions-new-imaging-modality-qak7ee3e7ky3"></link>
<id>urn:uuid:9e7978b8-6fcf-738f-ecf2-7d7bb57064cc</id>
<summary type="html"><![CDATA[MR Solutions brings new 3D, 1000 X magnification imaging modality to preclinical research]]></summary>
<updated>2016-02-22T15:50:05+00:00</updated>
</entry>
</feed>